Avivagen Announces Chief Executive Officer and Issuance of Third Quarter Results
September 07, 2017 17:00 ET
|
Avivagen Inc.
OTTAWA, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a corporation with a proven and commercially-ready, patent-protected product...
Avivagen Announces Scale Up of Commercial Roll Out for OxC-beta™ Livestock in the Philippines
August 16, 2017 07:30 ET
|
Avivagen Inc.
OTTAWA, Ontario, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a corporation with a proven and commercially-ready, patent-protected...
Cesar Millan to Endorse Avivagen’s Companion Animal Health Product Vivimune Health Chews
July 10, 2017 07:30 ET
|
Avivagen Inc.
OTTAWA, July 10, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (“Avivagen” or the “Corporation” (TSX-V:VIV) (OTC Pink:CHEXF), a life sciences innovation company with a series of patent protected products...
Avivagen Retains Hybrid Financial Inc. for Investor Relations Activities
July 04, 2017 08:00 ET
|
Avivagen Inc.
OTTAWA, July 04, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSX-V:VIV) (OTC Pink:CHEXD) (“Avivagen” or the “Corporation”), a corporation with a proven and commercially-ready, patent-protected product...
Avivagen Provides Business Updates
June 05, 2017 08:00 ET
|
Avivagen Inc.
OTTAWA, June 05, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSX-V:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a corporation with a proven and commercially-ready, patent-protected product...
Avivagen Announces Grant of Stock Options
May 30, 2017 13:20 ET
|
Avivagen Inc.
OTTAWA, May 30, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF), a life sciences company commercializing products to replace the antibiotics used in livestock feeds, is...
Avivagen Announces Third Purchase Order of OxC-Beta™ Livestock from UNAHCO Inc.
May 26, 2017 09:35 ET
|
Avivagen Inc.
OTTAWA, May 26, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a corporation with a proven and commercially-ready, patent protected product...
Avivagen Announces Completion of Share Consolidation
May 24, 2017 16:00 ET
|
Avivagen Inc.
OTTAWA, May 24, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a Corporation with a proven and commercially-ready, patent-protected product...
Avivagen Announces Engagement of Regulatory Consulting Firm
May 12, 2017 08:00 ET
|
Avivagen Inc.
OTTAWA, Ontario, May 12, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a Corporation with a proven and commercially-ready, patent-protected...
Avivagen Inc. Announces Consolidation of Common Shares
May 08, 2017 14:07 ET
|
Avivagen Inc.
OTTAWA, Ontario, May 08, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV), (OTC Pink:CHEXF) (Avivagen or the Corporation), a company with a proven and commercially-ready, patent-protected product...